Related references
Note: Only part of the references are listed.Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment
Mohsen Heidary et al.
EUROPEAN JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY (2022)
Early detection of Pre-XDR TB with line probe assay in a high TB burden country
Laura Madukaji et al.
AFRICAN HEALTH SCIENCES (2021)
World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update
Fuad Mirzayev et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: A subsequent study of a national survey
Guirong Wang et al.
JOURNAL OF INFECTION (2021)
The Epidemiology of first and second-line drug-resistance Mycobacterium tuberculosis complex common species: Evidence from selected TB treatment initiating centers in Ethiopia
Biniyam Dagne et al.
PLOS ONE (2021)
Frequency and patterns of first- and second-line drug resistance-conferring mutations in Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients in a cross-sectional study in Tigray Region, Ethiopia
Letemichael Negash Welekidan et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2021)
Epidemiological profile of multidrug-resistant and extensively drug-resistant Mycobacterium Tubrculosis among Congolese patients
Darrel Ornelle Elion Assiana et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2021)
Predictors of Drug-Resistant Tuberculosis among High-Risk Population Diagnosed under National Program Conditions in the Littoral Region, Cameroon
Teyim Pride Mbuh et al.
BIOMED RESEARCH INTERNATIONAL (2021)
Molecular characterization of multidrug-resistant tuberculosis against levofloxacin, moxifloxacin, bedaquiline, linezolid, clofazimine, and delamanid in southwest of China
Huiwen Zheng et al.
BMC INFECTIOUS DISEASES (2021)
Assessment of burden of drug-resistant tuberculosis at a tertiary care centre in northern India: a prospective single centre cohort study
Richa Misra et al.
BMJ OPEN (2021)
Resistance to Second-Line Anti-TB Drugs in Cambodia: A Phenotypic and Genetic Study
Sokleaph Cheng et al.
INFECTION AND DRUG RESISTANCE (2021)
Drug Resistance Pattern of M. tuberculosis Complex in Oromia Region of Ethiopia
Hussien Bedru et al.
INFECTION AND DRUG RESISTANCE (2021)
Prevalence of Mycobacterium tuberculosis resistant to bedaquiline and delamanid in China
Wencong He et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2021)
Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition
Cong Yao et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2021)
First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil
Richard Steiner Salvato et al.
INFECTION GENETICS AND EVOLUTION (2020)
The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia
Agumas Shibabaw et al.
PLOS ONE (2020)
Epidemiology and treatment outcome of MDR and pre-XDR TB in international migrants at two reference centers in the North of Italy: a cross-sectional study coordinated by Stop TB Italia Onlus
N. Riccardi et al.
PUBLIC HEALTH (2020)
The epidemiological characteristics and profile of drug-resistant tuberculosis among children with tuberculosis in Sichuan, China, 2015-2018 A retrospective study
Yuanhong Xu et al.
MEDICINE (2020)
Molecular characterization and drug resistance patterns of Mycobacterium tuberculosis complex in extrapulmonary tuberculosis patients in Addis Ababa, Ethiopia
Getu Diriba et al.
PLOS ONE (2020)
Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from Sao Paulo, Brazil
Tania Matsui et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2020)
Second-line Drug Resistance Characterization in Mycobacterium tuberculosis by Genotype MTBDRsl Assay
Sunil Sethi et al.
JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH (2020)
The double burden of diabetes and global infection in low and middle-income countries
Susanna Dunachie et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2019)
Prevalence, associated factors, outcomes and transmission of extensively drug-resistant tuberculosis among multidrug-resistant tuberculosis patients in Sao Paulo, Brazil: a cross-sectional study
J. F. Gallo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
XJ Resistance to first- and second-line antituberculosis drugs in Southern Taiwan: Implications for empirical treatment
Cheng-Yu Kuo et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2018)
Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea
Jeong Seong Yang et al.
ANNALS OF LABORATORY MEDICINE (2018)
Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan
A. Javaid et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2017)
Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India
S. K. Sharma et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2017)
Performance of the GenoType MTBDRsl assay for the detection second-line anti-tuberculosis drug resistance
Young Seok Lee et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2017)
Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design
Jeong Ha Mok et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2017)
Extensively drug-resistant tuberculosis (XDR-TB) in Morocco
Wifak Ennassiri et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2017)
Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand
Risara Jaksuwan et al.
INFECTION AND DRUG RESISTANCE (2017)
Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing
Jun Chen et al.
BMC INFECTIOUS DISEASES (2017)
Drug-resistant tuberculosis in Central Mozambique: the role of a rapid genotypic susceptibility testing
Evangelina Inacio Namburete et al.
BMC INFECTIOUS DISEASES (2016)
A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India
Parul Singhal et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2016)
Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011
Hoa Binh Nguyen et al.
WESTERN PACIFIC SURVEILLANCE AND RESPONSE (2016)
Drug-resistance pattern of Mycobacterium tuberculosis strains from patients with pulmonary and extrapulmonary tuberculosis during 2006 to 2013 in a Korean tertiary medical center
Ho Young Lee et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2015)
Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Greater Metropolitan Mumbai: Trends over Time
Alpa Dalal et al.
PLOS ONE (2015)
Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments
Carson Ka-Lok Lo et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Prediction of XDR/pre-XDR tuberculosis by genetic mutations among MDR cases from a hospital in Shandong, China
Haiying Wang et al.
TUBERCULOSIS (2014)
Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China
Xiaoliang Yuan et al.
BMC INFECTIOUS DISEASES (2013)
Drug resistance patterns in 111 cases of drug-resistant tuberculosis spine
Kapil Mohan et al.
EUROPEAN SPINE JOURNAL (2013)
Frequency of extensively drug-resistant tuberculosis (XDR-TB) among re-treatment cases in NIDCH, Dhaka, Bangladesh
Rashed Noor et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2013)
Characterization of extensively drug-resistant Mycobacterium tuberculosis in Nepal
Ajay Poudel et al.
TUBERCULOSIS (2013)
PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts
Elaine M. Beller et al.
PLOS MEDICINE (2013)
Molecular Characterization of Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Strains in Jiangxi, China
Xiaoliang Yuan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Multi-Ethnic Region, Xinjiang Uygur Autonomous Region, China
Ying-Cheng Qi et al.
PLOS ONE (2012)
Pre-XDR & XDR in MDR and Ofloxacin and Kanamycin resistance in non-MDR Mycobacterium tuberculosis isolates
Amita Jain et al.
TUBERCULOSIS (2012)
Multidrug and extensively drug-resistant tuberculosis in Lisbon and Vale do Tejo, Portugal, from 2008 to 2010
R. Macedo et al.
INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY (2012)
The National Status of Tuberculosis Using Nationwide Medical Records Survey of Patients with Tuberculosis in Korea
Yoon-Sung Park et al.
TUBERCULOSIS AND RESPIRATORY DISEASES (2012)
MDR- and XDR-TB among suspected drug-resistant TB patients in a tertiary care hospital in India
Prince James et al.
CLINICAL RESPIRATORY JOURNAL (2011)
Emergence of Increased Resistance and Extensively Drug-Resistant Tuberculosis Despite Treatment Adherence, South Africa
Alistair D. Calver et al.
EMERGING INFECTIOUS DISEASES (2010)
Extensively Drug-Resistant Tuberculosis: A New Face to an Old Pathogen
Sheela Shenoi et al.
ANNUAL REVIEW OF MEDICINE (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a medical center in Taiwan
Chih-Cheng Lai et al.
CLINICAL INFECTIOUS DISEASES (2008)
Extensively drug-resistant tuberculosis in California, 1993-2006
Ritu Banerjee et al.
CLINICAL INFECTIOUS DISEASES (2008)
Assessing heterogeneity in meta-analysis:: Q statistic or I2 index?
Tania B. Huedo-Medina et al.
PSYCHOLOGICAL METHODS (2006)
Share Paper
